ConductScience.org, home

Paper39808673

Naturally occurring variation in a cytochrome P450 modifies thiabendazole responses independently of beta-tubulin.

Collins JB and 13 others. PLoS Pathog, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Naturally occurring variation in a cytochrome P450 modifies thiabendazole responses independently of beta-tubulin. Papers, record 39808673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39808673

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Naturally occurring variation in a cytochrome P450 modifies thiabendazole responses independently of beta-tubulin.
PubMed
Journal
PLoS Pathog
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-09-11
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Collins JBJ Bhttps://orcid.org/0000-0003-0808-5216
2Dilks CMClayton M
3Hahnel SRSteffen R
4Rodriguez BBriana
5Fox BWBennett W
6Redman EElizabeth
7Yu JJingfang
8Cooke BBrittany
9Sihuta KKateryna
10Zamanian MMostafa
11Roy PJPeter J
12Schroeder FCFrank C
13Gilleard JSJohn S
14Andersen ECErik Chttps://orcid.org/0000-0003-0229-9651

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Caenorhabditis elegansMajor topic
Cytochrome P-450 Enzyme SystemMajor topic
TubulinMajor topic
ThiabendazoleMajor topic
Caenorhabditis elegans ProteinsMajor topic
Drug ResistanceMajor topic
AnthelminticsMajor topic
Animals
Quantitative Trait Loci
Genome-Wide Association Study

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI153088NIAID NIH HHSUnited StatesR01AI153088PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133317926Complementary Approaches with Free-living and Parasitic Nematodes to Understanding Anthelmintic Resistance.Trends Parasitol2021https://conductscience.org/library/papers/33317926PubMed
229601575Discovery of genomic intervals that underlie nematode responses to benzimidazoles.PLoS Negl Trop Dis2018https://conductscience.org/library/papers/29601575PubMed
322669657Caenorhabditis elegans as a model in developmental toxicology.Methods Mol Biol2012https://conductscience.org/library/papers/22669657PubMed
437855690CaeNDR, the Caenorhabditis Natural Diversity Resource.Nucleic Acids Res2024https://conductscience.org/library/papers/37855690PubMed
539572328Integrating metabolomics into the diagnosis and investigation of anthelmintic resistance.Trends Parasitol2024https://conductscience.org/library/papers/39572328PubMed
630471287Deep amplicon sequencing as a powerful new tool to screen for sequence polymorphisms associated with anthelmintic resistance in parasitic nematode populations.Int J Parasitol2019https://conductscience.org/library/papers/30471287PubMed
732858477Quantitative benzimidazole resistance and fitness effects of parasitic nematode beta-tubulin alleles.Int J Parasitol Drugs Drug Resist2020https://conductscience.org/library/papers/32858477PubMed
832385045The Gene scb-1 Underlies Variation in Caenorhabditis elegans Chemotherapeutic Responses.G3 (Bethesda)2020https://conductscience.org/library/papers/32385045PubMed
92513255Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.Genetics1989https://conductscience.org/library/papers/2513255PubMed
1015034147MUSCLE: multiple sequence alignment with high accuracy and high throughput.Nucleic Acids Res2004https://conductscience.org/library/papers/15034147PubMed
1133720993Two novel loci underlie natural differences in Caenorhabditis elegans abamectin responses.PLoS Pathog2021https://conductscience.org/library/papers/33720993PubMed
128096381Effect of selection for benzimidazole resistance in Haemonchus contortus on beta-tubulin isotype 1 and isotype 2 genes.Biochem Biophys Res Commun1993https://conductscience.org/library/papers/8096381PubMed
1325770127A Powerful New Quantitative Genetics Platform, Combining Caenorhabditis elegans High-Throughput Fitness Assays with a Large Collection of Recombinant Strains.G3 (Bethesda)2015https://conductscience.org/library/papers/25770127PubMed
1428746337Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.PLoS Negl Trop Dis2017https://conductscience.org/library/papers/28746337PubMed
1532122383New codon 198 β-tubulin polymorphisms in highly benzimidazole resistant Haemonchus contortus from goats in three different states in Sudan.Parasit Vectors2020https://conductscience.org/library/papers/32122383PubMed
1621468315Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.PLoS Negl Trop Dis2011https://conductscience.org/library/papers/21468315PubMed
177911975Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1.Mol Biochem Parasitol1994https://conductscience.org/library/papers/7911975PubMed
1839668355
Differences in constitutive gene expression of cytochrome P450 enzymes and ATP-binding cassette transporter gene expression between a susceptible and a highly macrocyclic lactone-resistant Haemonchus contortus isolate in the absence of drug-inducible expression.
Parasit Vectors2024https://conductscience.org/library/papers/39668355PubMed
1934637983Newly identified parasitic nematode beta-tubulin alleles confer resistance to benzimidazoles.Int J Parasitol Drugs Drug Resist2021https://conductscience.org/library/papers/34637983PubMed
2038956039Cyprocide selectively kills nematodes via cytochrome P450 bioactivation.Nat Commun2024https://conductscience.org/library/papers/38956039PubMed

See all 58 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42947444
Synthetic Strategy to Novel Highly Functionalized Furan Analogues Bearing Imidazole-Thiazole Hybrids: Structural Characterization, Nanoparticle Formulations, Antimicrobial Evaluation, Molecular Docking Studies, and Molecular Dynamic Simulations.
Chem Biodivers2026https://conductscience.org/library/papers/42947444PubMed
42766653The nematode Caenorhabditis elegans has a cationic amphiphilic drug (CAD) defense system.PLoS Biol2026https://conductscience.org/library/papers/42766653PubMed
42247472Evaluating beta-tubulin variants as predictors of benzimidazole resistance across Caenorhabditis nematodes.PLoS Pathog2026https://conductscience.org/library/papers/42247472PubMed
41928777Methods for single-pair Ascaridia galli genetic crosses.MicroPubl Biol2026https://conductscience.org/library/papers/41928777PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39808673

GET https://conductscience.org/api/papers/v1/39808673/references?page=2